Neopterin and CXCL10 have been proposed as biomarkers for HAM/TSP activity and disease prognosis since increasing CSF levels of these factors correlate with rising scores in the Osame Motor Disability Score (39–41). Here, CXCL10 is linked to tropical spastic paraparesis.